The Eye Machine Introduces a New Way to Treat AMD
For years, millions of Americans have suffered from AMD. Age-Related Macular Degeneration (AMD) is an eye disease that causes the deterioration of central vision. It is normally found in patients who are over the age of 60 years old. As of 2010, Approximately 10 million Americans had advanced age-related macular degeneration, and that number is expected to grow to 18 million in 2050. As a result of this growing number, The Eye Machine, LLC has created a revolutionary new procedure that through their ground-breaking technology will help to treat those who suffer with AMD.
AMD is a breakdown of the macula in the retina. A “black cloud” forms in the patient’s central vision, making it difficult to perform everyday activities such as driving, reading, watching television, and working on a computer. This eye disease progressively deteriorates the patient’s vision. It can even impair their ability to see color and contrast in objects. The innovators of the technology behind The Eye Machine are dedicated to helping those who suffer with AMD regain some of their vision. By Improving the metabolism of the cells, it helps to generate healthier photoreceptors in the macula. This creates the potential for the improvement of the patient’s vision.
This effective, non-invasive treatment for AMD is revolutionary and is used for all forms of macular degeneration. The technology uses BioCurrent Therapy which emits targeted frequencies to stimulate a response at the retinal level. By doing this, the cells and blood vessels receive a better oxygen flow. This also allows more nutrition to be delivered to the cells.
The electrotherapy treatment delivers a low level of electric current to the eye. Each one-hour procedure, which incorporates a special type of goggle to deliver the current, has been shown by studies to improve movement of nutrition from the blood to the cells. These special goggles work with a generator station to deliver micro current in a patented waveform to four places on the closed eye lid. The four sites consist of the upper left lid, the lower left lid, upper right lid and lower right lid. Each area takes 40 seconds to deliver the electric current effectively.
While the technology still needs to complete a regulatory approval process with the FDA, it is expected to be the future of treating patients with AMD. They are located at 74-900 Highway 111, Suite 127, Indian Wells, California 92210. Read more about our exciting new technology on our website or contact us at (760) 292-2805 for more information.